MSLE
Satellos Bioscience Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$190.31M
P/E Ratio
—
EPS
$-1.95
Beta
1.14
52W High
$13.39
52W Low
$5.30
50-Day MA
$9.25
200-Day MA
$8.13
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Satellos Bioscience Inc. Common Stock
Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company is headquartered in Toronto, Canada.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-9.48M |
| EBITDA | $-35.82M |
| Operating Margin | 0.00% |
| Return on Equity | -70.50% |
| Return on Assets | -41.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.88 |
| Price-to-Book | 3.24 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 4.75 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $21.22M |
| Float | $18.02M |
| % Insiders | 6.37% |
| % Institutions | 49.70% |
Historical Volatility
HV 10-Day
75.12%
HV 20-Day
56.55%
HV 30-Day
49.84%
HV 60-Day
74.60%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($26.25 target)
5
BuyTurn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on MSLE and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/7/2026